Table 5.

Comparison between males and females in patients with non-small cell lung cancer (NSCLC)

Marker	NSCLC Male Median (IQR)	NSCLC Female Median (IQR)	P-value
TGF-β1 (ng/dl)	51.5 (46.8-64.0)	47.6 (34.2-57.9)	0.176
SMAD2 (ng/dl)	2.3 (1.7-2.5)	2.1 (1.7-2.5)	0.507
WNT3a (ng/dl)	3.0 (1.5-4.6)	2.0 (1.1-3.8)	0.027
CTNN-β1 (ng/dl)	3.6 (2.7-5.2)	3.5 (2.3-4.3)	0.309

TGF-β1 – transforming growth factor β1, SMAD2 – mothers against decapentaplegic homolog 2, Wnt3a – wingless-related integration site, CTNN-β1 – β-catenin